⌘K

Login Start Free

Home/Filings/4/0001578563-22-000025

4//SEC Filing

KAPLAN GILLA 4

Accession 0001578563-22-000025

CIK 0001534120other

View on SEC.gov Company Profile

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 4:07 PM ET

Size

5.4 KB

Accession

0001578563-22-000025

Insider Transaction Report

Form 4

Period: 2022-06-30

Avalo Therapeutics, Inc.AVTX

Director

Transactions

Award
Stock Option (Right to Buy)
2022-06-30+44,115→ 44,115 total
Exercise: $0.50From: 2022-06-30Exp: 2032-06-30→ Common Stock (44,115 underlying)

Footnotes (1)

[F1]100% of the stock option will immediately vest on the date that it is granted.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Avalo Therapeutics, Inc.

CIK 0001534120

Entity typeother

Related Parties

1

filerCIK 0001247024

Filing Metadata

Form type: 4
Filed: Jun 30, 8:00 PM ET
Accepted: Jul 1, 4:07 PM ET
Size: 5.4 KB

View on SEC.gov